Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Qiheng Gou"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Breast cancer (BC) has the second highest incidence among cancers and is the leading cause of death among women worldwide. The human epidermal growth factor receptor 2 (HER2) is overexpressed in approximately 20%–30% of BC patients. The development
Externí odkaz:
https://doaj.org/article/1e17efc17f8542039234b52e459cd0a1
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-21 (2024)
Abstract Lung cancer is still the leading cause of cancer-related mortality. Over the past two decades, the management of non-small cell lung cancer (NSCLC) has undergone a significant revolution. Since the first identification of activating mutation
Externí odkaz:
https://doaj.org/article/04e381e7a49347ff895ad4522a2b0ef0
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 5, Pp 2106-2121 (2024)
Summary: E2F transcription factors (E2Fs) are a group of genes that encode a family of transcription factors. They have been identified as being involved in the tumor progression of various cancer types. However, little is known about the expression
Externí odkaz:
https://doaj.org/article/bd21c72b7b724ee4b819db6918b87087
Publikováno v:
Breast, Vol 66, Iss , Pp 89-96 (2022)
Background: Little is known about the benefits of adjuvant endocrine therapy (ET) in low ER-positive breast cancer (1%–10%) patients. We analyzed the association between ET and breast cancer-specific survival (BCSS) in these patients with respect t
Externí odkaz:
https://doaj.org/article/a063a15878394e37a47215f9a1e27fb6
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The effect of long noncoding RNAs (lncRNAs) on the radiotherapy response has been gradually revealed. This systematic review and meta-analysis aimed to evaluate the association between the function and underlying mechanism of lncRNAs in regu
Externí odkaz:
https://doaj.org/article/033918c1634d49d7a949945b1b08d1f0
Autor:
Feng Wang, Fen Zhao, Li Zhang, Lai Xiong, Qing Mao, Yanhui Liu, Xiaoguang Qiu, Xiang Wang, Lin Shui, Xi Chen, Kexing Ren, Pixian Shui, Qiongwen Zhang, Yifei Deng, Weimin Li, Xiaoqi Xie, Dengbin Wu, Tao Li, Jinyi Lang, Lei Liu, Huaying Chen, Jianguo Xu, Sen Bai, Zhiping Li, Qiang Yue, Ni Chen, Bingwen Zhou, Cheng Yi, Yuquan Wei, Yuchuan Fu, Yong Luo, Qiheng Gou, Lunxu Liu, Yuanzhao Liu, Jingbo Kang, Junjie Wang, Dongcun Jing, Fuquan Zhang, Xiaoyan Yang, Xianfeng Li, Tao Jiang, Zongcun Zhang, Yizhi Zhou, Junlin Yi
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-9 (2022)
Abstract Background Cell division cycle 6 (CDC6) has been proven to be associated with the initiation and progression of human multiple tumors. However, it’s role in glioma, which is ranked as one of the common primary malignant tumor in the centra
Externí odkaz:
https://doaj.org/article/1190ce211bd44a7391de4b233faa8d8c
Autor:
Yuxin Xie, Qiheng Gou, Yingjie Zhang, Keqi Xie, Dan Zheng, Chuanxu Luo, Jiaojiao Suo, Xiaorong Zhong, Ting Luo
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Little is known about whether age at initial diagnosis influences the prognosis of recurrent metastatic breast cancer (rMBC). Here, we analyzed the association between age at initial diagnosis and rMBC mortality in China. Methods
Externí odkaz:
https://doaj.org/article/f915d35f505f427687bf835141223b20
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: The role of the tumor microenvironment (TME) in predicting prognosis and therapeutic efficacy has been demonstrated. Nonetheless, no systematic studies have focused on TME patterns or their function in the effectiveness of immunotherapy i
Externí odkaz:
https://doaj.org/article/7b309ae53d2442e18f5592e39f92437d
Publikováno v:
Cancer Control, Vol 29 (2022)
Objectives Although metastatic breast cancer (MBC) is considered incurable, a specific subset of patients exhibits prolonged survival and even achieve a “cure”. We retrospectively identified predictive prognostic factors and systemic therapy mode
Externí odkaz:
https://doaj.org/article/dde16e08cddc4e67a192625d4f6b1141
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIntracranial solitary fibrous tumor/hemangiopericytoma (SFT/HPC) is a novel rare disease after the 2016 WHO reclassification. Surgery is the main treatment. Postoperative adjuvant radiotherapy is often used, but the effects of different rad
Externí odkaz:
https://doaj.org/article/a367803755cf41029926f58bae083792